MyFinsight
Home
About
Contact
nmra: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, NMRA has $177,833K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
177,833
223,825
Total stockholders' equity
132,161
182,879
Total liabilities and stockholders' equity
177,833
223,825
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$5,557K
Short-term marketable
securities
$42,454K
Cash and cash
equivalents
$129,071K
Other assets
$197K
Operating lease
right-of-use assets
$474K
Property and equipment,
net
$80K
Total current assets
$177,082K
Total assets
$177,833K
Total liabilities and
stockholders' equity
$177,833K
Total stockholders'
equity
$132,161K
Total liabilities
$45,672K
Accumulated deficit
-$1,124,699K
Accumulated other
comprehensive income
$9K
Additional paid-in capital
$1,256,835K
Operating lease
liabilities, noncurrent
$267K
Long term debt, net
$19,563K
Total current
liabilities
$25,842K
Common stock
$16K
Operating lease
liabilities, current portion
$256K
Early exercise
liability, current portion
$55K
Accrued liabilities
$24,982K
Accounts payable
$549K
Subscribe for Financial Insights
Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. (NMRA)